ATRI
vs
S&P 500
ATRI
S&P 500
Over the past 12 months, ATRI has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +16% growth.
Stocks Performance
ATRI vs S&P 500
Performance Gap
ATRI vs S&P 500
Performance By Year
ATRI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.